Human mesenchymal stem cells: From immunophenotyping by flow cytometry to clinical applications

Abstract

Modern medicine will unequivocally include regenerative medicine as a major breakthrough in the re-establishment of damaged or lost tissues due to degenerative diseases or injury. In this scenario, millions of patients worldwide can have their quality of life improved by stem cell implantation coupled with endogenous secretion or administration of survival and differentiation promoting factors. Large efforts, relying mostly on flow cytometry and imaging techniques, have been put into cell isolation, immunophenotyping, and studies of differentiation properties of stem cells of diverse origins. Mesenchymal stem cells (MSCs) are particularly relevant for therapy due to their simplicity of isolation. A minimal phenotypic pattern for the identification of MSCs cells requires them to be immunopositive for CD73, CD90, and CD105 expression, while being negative for CD34, CD45, and HLA-DR and other surface markers. MSCs identified by their cell surface marker expression pattern can be readily purified from patient's bone marrow and adipose tissues. Following expansion and/or predifferentiation into a desired tissue type, stem cells can be reimplanted for tissue repair in the same patient, virtually eliminating rejection problems. Transplantation of MSCs is subject of almost 200 clinical trials to cure and treat a very broad range of conditions, including bone, heart, and neurodegenerative diseases. Immediate or medium term improvements of clinical symptoms have been reported as results of many clinical studies. ' 2012 International Society for Advancement of Cytometry

Cardiac Analysis of Autologous Transplantation of Cocultured Skeletal Myoblasts and Mesenchymal Cells in a Rat Model Doxorubicin-Induced Cardiotoxicity: Histopathological and Functional Studies

“…Flow cytometric analyses were employed to mesenchymal stem cell characterization by CD73, CD90, and CD105 positive cell surface marker expression, while being negative for CD34, CD45, and HLA-DR surface markers [12,22].…”

Human Marrow Stromal Cells Downsize the Stem Cell Fraction of Lung Cancers by Fibroblast Growth Factor 10

“…After antigen unmasking for 10 min at 95 to 100°C in 10 mM sodium citrate buffer (pH 6.0), the specimens were stained with fluorescein isothiocyanate (FITC)-conjugated anti-human CD90 antibody (clone 5E10; BD Biosciences) and phycoerythrin (PE)-conjugated anti-FGF10 antibody (Bioss, Woburn, MA). CD90 is commonly regarded as an essential marker of human MSCs (15,16). Nuclei were counterstained by using Vectashield mounting medium with DAPI (4=,6-diamidino-2-phenylindole) (Vector Laboratories, Burlingame, CA).…”

Membrana amniótica: fonte alternativa de células-tronco mesenquimais em diversas espécies animais

“…As células-tronco somáticas são consideradas células multipotentes que possuem potencial de se diferenciarem em múltiplas linhagens celulares, sendo classificadas em células hematopoiéticas e mesenquimais. São consideradas relevantes no uso da terapia celular devido sua facilidade de isolamento de quase todos os tecidos adultos, cultivo e formação de banco de células (Dominici et al 2006, Del Carlo et al 2008, Nery et al 2013.…”